All Regulatory Rapporteur articles in June 2025
View all stories from this issue.
-
InterviewFAMHP: The role of the Belgian Agency in advancing public health
This interview with Professor Hugues Malonne, Chief Executive Officer of the Belgian Federal Agency for Medicines and Health Products (FAMHP) discusses the Agency’s role in helping shape regulatory affairs and improving health.
-
PodcastsRegRapPod − InConversation with Hugues Malonne
InConversation talks about the role of the Federal Agency for Medicines and Health Products (FAMHP) with Hugues Malonne, Chief Executive Officer at FAMHP
-
JournalDivergence on the definition of regulatory reliance in international regions: Is there room for convergence?
The article explores how reliance pathways can be used for MAAs and incorporates AstraZeneca’s research findings on this topic.
-
JournalMedical device standards update: May 2025
This article updates the progress of applicable medical device standards to May 2025.
-
JournalPromoting the use of bacteriophages in animals to reduce antimicrobial resistance
This article explores bacteriophage-based products for animals and how to reduce antimicrobial resistance (AMR).
-
JournalSandbox of trust: Regulated AI for health promotion and disease prevention
This article explores the capacity and potential for AI tools in analysing health data and helping with disease prevention.
-
JournalNew European Medicines Agency fees: The effect on veterinary medicines
In response to the EMA’s new fee system, this article dicusses the impact on marketing authorisation holders who place veterinary medicines on the market.
-
JournalVeterinary Regulation 2019/6: Impact, challenges and the future: Interview with Ivo Claassen
In this interview, Claire McDermott talks with Ivo Classen, Head of the Veterinary Medicines Division and Deputy Executive Director of the European Medicines Agency on the impact of Veterinary Regulation 2019/6.
-
ContentsJune 2025 – Contents
The June issue of Regulatory Rapporteur focuses on veterinary medicines.
-
EditorialVeterinary medicines: Translating regulation into practice
This issue looks at the impact of the Veterinary Regulation 2019/6, the effect of the new EMA fees on marketing authorisation holders, and the regulatory challenges associated with the practical use of bacteriophages in veterinary medicine.